obesity drug news today october 2025 glp-1 Outlook for in 2025: more than a transition year GLP-1 drug access and 2026
Description
Results showed: Approximately 60% of participants lost at least 5% of their initial body weight (around 5.4 kg )
doi: 10.3389/fendo.2018.00584 [DOI] [PMC free article] [PubMed] [Google Scholar] 34.Gaykema RP, Newmyer BA, Ottolini M, et al
Altogether, these reasons make allulose an attractive candidate for the dietary management of metabolic disorders, both by displacing dietary fructose as well as providing putative metabolic benefits itself [1,2,3]
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC
Watson KT, Wroolie TE, Tong G, Foland-Ross LC, Frangou S, Singh M, et al
This can influence several cellular functions, including insulin secretion in pancreatic islet cells, as depicted in the schematic
